Stock OCGN OCUGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Ocugen, Inc.

Equities

OCGN

US67577C1053

Delayed Nasdaq
Other stock markets
 03:48:53 2024-04-16 pm EDT 		5-day change 1st Jan Change
1.581 USD -0.55% Intraday chart for Ocugen, Inc. -7.02% +176.52%
Apr. 10 Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for Ocu400?Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication CI
Apr. 08 Ocugen Gets FDA Clearance for IND Amendment for OCU400 DJ

Chart calendar Ocugen, Inc.

bc905c65b828d3caa641beefc67b.WwG5oaRELT5uFSKgfXgUCk8sPd4I7FR05NHNRMe-INY.ATbUwNAXYWspb2j4DU1TY3dPUvNRviYBqZmBE7LORqwMRO_oyTEdDzFhTQ~8bb12b44e3ccabbb224a9932b5cec192

Upcoming events on Ocugen, Inc.

2024-04-17 10:00 am Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-05-02 Q1 2024 Earnings Release (Projected)
2024-08-01 Q2 2024 Earnings Release (Projected)
2024-11-07 Q3 2024 Earnings Release (Projected)
2025-03-27 Q4 2024 Earnings Release (Projected)

Past events on Ocugen, Inc.

2024-04-02 08:30 am Q4 2023 Earnings Call
2024-04-02 08:00 am Q4 2023 Earnings Release
2024-03-08 04:45 pm Foundation Fighting Blindness Investing in Cures Summit
2024-03-01 06:05 am Abu Dhabi Family Office Summit
2024-02-26 01:45 pm BIO CEO & Investor Conference
2024-02-21 10:00 am Clinical Show
2024-02-07 09:00 am Pharma Market Research Conference
2023-12-04 02:00 pm Noble Capital Markets Emerging Growth Equity Conference
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-11-09 06:30 am Q3 2023 Earnings Release
2023-10-11 08:15 pm Cell & Gene Meeting on the Mesa Conference
2023-10-05 11:20 am Gene Therapy for Ophthalmic Disorders Conference
2023-10-03 01:30 pm Chardan Genetic Medicines Conference - Fireside Chat
2023-10-03 09:00 am Gene Therapy for Ophthalmic Disorders Conference - Workshop
2023-09-26 01:00 pm Cantor Global Healthcare Conference
2023-09-13 08:30 am OCU400 Phase 1/2 Trial Results Call
2023-08-22 08:30 am Q2 2023 Earnings Call
2023-08-21 04:32 pm Q2 2023 Earnings Release
2023-06-09 08:00 am Annual General Meeting
2023-06-05 04:30 pm BIO International Convention

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,04
0,01
296.47%		0,00
0,00
- 		0,00
2,17
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-14,2
-12,9
-9.77%		-21,3
-15,8
-34.85%		-58,0
-54,2
-6.98%		-84,9
-82,0
-3.55%
-72,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-58,4
-53,2
-9.86%		-81,4
-81,0
-0.46%
-69,0

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-58,4
-53,1
-9.82%		-81,4
-81,0
-0.46%
-69,0

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-0,31
-0,36
13.89%		-0,30
-0,30
0%		-0,38
-0,38
0%
-0,28

Announcement Date27/03/2018/03/2125/02/2228/02/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
13,8
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
2,17
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,8
-8,93
-20.87%		-14,6
-10,8
-35.04%		-18,0
31,4
-157.51%		-19,6
-17,8
-10.02%		-23,1
-22,0
-5.09%		-24,2
-23,8
-1.33%		-17,8
-25,6
30.66%		-23,7
-17,7
-34.45%		-15,4
-18,9
18.35%
-15,4













Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,8
-7,92
-36.49%		-14,6
-9,38
-55.52%		-18,0
34,0
-152.97%		-19,5
-17,8
-9.49%		-21,9
-22,0
0.35%		-21,9
-23,8
7.95%		-16,5
-25,6
35.55%		-22,9
-17,3
-32.63%		-14,2
-18,6
24.03%
-15,4













Net income
Million USD		Released
Forecast
Spread 		-10,8
-7,92
-35.84%		-14,6
-9,38
-55.52%		-18,0
34,0
-152.97%		-19,5
-17,8
-9.49%		-21,9
-22,0
0.35%		-21,9
-23,8
7.95%		-16,5
-25,1
34.24%		-22,9
-17,3
-32.63%		-14,2
-18,6
24.03%
-15,4













EPS
USD		Released
Forecast
Spread 		-0,05
-0,04
-25%		-0,07
-0,07
0%		-0,09
0,01
-775.17%		-0,09
-0,08
-18.42%		-0,10
-0,10
-1.7%		-0,10
-0,10
0%		-0,07
-0,11
35.19%		-0,10
-0,07
-37.93%		-0,06
-0,07
14.29%
-0,06


-0,07


-0,07


-0,07


-0,08

Announcement Date09/11/2125/02/2206/05/2205/08/2208/11/2228/02/2305/05/2321/08/2309/11/23-----

Upcoming sector events for Ocugen, Inc.

2024-04-17 HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release
2024-04-21 MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release
2024-04-22 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release
2024-04-22 HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release
2024-04-23 SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
2024-04-23 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
2024-04-23 ALKERMES PLC: Q1 2024 Earnings Release (Projected)
2024-04-23 CUREVAC N.V.: Q4 2023 Earnings Release (Projected)
2024-04-23 HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release
More events

Past sector events for Ocugen, Inc.

2024-04-10 04:10 pm PHARVARIS N.V.: Q4 2023 Earnings Release
2024-04-10 01:22 am POLARIS GROUP: March 2024 Sales and Revenue Release
2024-04-02 02:30 am ABIVAX: Q4 2023 Earnings Release
2024-04-01 09:00 am BIOMEA FUSION, INC.: Q4 2023 Earnings Release
2024-03-28 10:42 pm ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release
2024-03-28 04:28 pm CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release
2024-03-28 04:05 pm ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release
2024-03-28 07:10 am HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release
2024-03-27 JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release
2024-03-27 10:25 am PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OCGN Stock
  4. Calendar Ocugen, Inc.